Cargando…

Study protocol for assessing the user acceptance, safety and efficacy of a tablet-based workflow and decision support system with incorporated basal insulin algorithm for glycaemic management in participants with type 2 diabetes receiving home health care: A single-centre, open-label, uncontrolled proof-of-concept study

INTRODUCTION: Diabetes management can be especially complex for older adults who receive health care at home. Thus, international guidelines recommend basal-insulin regimens due to simpler handling and low hypoglycaemia risk. A basal-insulin algorithm (including basal-plus) was developed to also inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Libiseller, Angela, Kopanz, Julia, Lichtenegger, Katharina M., Mader, Julia K., Truskaller, Thomas, Lackner, Bettina, Aberer, Felix, Pandis, Marlene, Reinisch-Gratzer, Johanna, Ambrosch, Gisela C., Sinner, Frank, Pieber, Thomas R., Donsa, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399114/ https://www.ncbi.nlm.nih.gov/pubmed/32775762 http://dx.doi.org/10.1016/j.conctc.2020.100620

Ejemplares similares

Digital algorithm-guided insulin therapy in home healthcare for elderly persons with type 2 diabetes: A proof-of-concept study
por: Kopanz, Julia, et al.
Publicado: (2022)

GlucoTab‐guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes
por: Aberer, Felix, et al.
Publicado: (2018)

Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different Wards
por: Neubauer, Katharina M., et al.
Publicado: (2015)

Evaluation of an implemented new insulin chart to improve quality and safety of diabetes care in a large university hospital: a follow-up study
por: Kopanz, Julia, et al.
Publicado: (2021)

Improved glycaemic control and treatment satisfaction with a simple wearable 3‐day insulin delivery device among people with Type 2 diabetes
por: Mader, J. K., et al.
Publicado: (2018)

A head‐to‐head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot
por: Moser, Othmar, et al.
Publicado: (2018)

Patients with healed diabetic foot ulcer represent a cohort at highest risk for future fatal events
por: Mader, Julia K., et al.
Publicado: (2019)

Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid‐induced hyperglycemia in patients with acute graft‐versus‐host disease: A randomized trial
por: Aberer, Felix, et al.
Publicado: (2018)

IPO: a tool for automated optimization of XCMS parameters
por: Libiseller, Gunnar, et al.
Publicado: (2015)

Medication errors in type 2 diabetes from patients’ perspective
por: Mader, Julia K., et al.
Publicado: (2022)

Adverse body composition and lipid parameters in patients with prolactinoma: a case-control study
por: Posawetz, Anna Sophia, et al.
Publicado: (2021)

Enhanced Absorption of Insulin Aspart as the Result of a Dispersed Injection Strategy Tested in a Randomized Trial in Type 1 Diabetic Patients
por: Mader, Julia K., et al.
Publicado: (2013)

An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery
por: Narath, Sophie H., et al.
Publicado: (2016)

Improvement of the Bioavailability and Glycaemic Metabolism of Cinnamon Oil in Rats by Liquid Loadable Tablets
por: Han, Chunchao, et al.
Publicado: (2012)

Accuracy Assessment of the GlucoMen(®) Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study
por: Hochfellner, Daniel A., et al.
Publicado: (2022)

Reply to Freckmann et al. Comment on “Hochfellner et al. Accuracy Assessment of the GlucoMen(®) Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study. Biosensors 2022, 12, 106”
por: Hochfellner, Daniel A., et al.
Publicado: (2023)

Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2017)

Glycaemic impact of treatment intensification in patients with type 2 diabetes uncontrolled with oral antidiabetes drugs or basal insulin
por: Buysman, Erin K., et al.
Publicado: (2018)

Diabetesmanagement im Krankenhaus (Update 2023)
por: Mader, Julia K., et al.
Publicado: (2023)

Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study
por: Bally, Lia, et al.
Publicado: (2017)

Canonical Density Matrices from Eigenstates of Mixed Systems §
por: Kourehpaz, Mahdi, et al.
Publicado: (2022)

Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes—A single-centre, prospective, controlled observational study
por: Moser, Othmar, et al.
Publicado: (2020)

Successful Medical Treatment of Adult Nesidioblastosis With Pasireotide over 3 Years: A Case Report
por: Schwetz, Verena, et al.
Publicado: (2016)

Impact of pharmacist-led care on glycaemic control of patients with uncontrolled type 2 diabetes: a randomised controlled trial in Nigeria
por: David, Emmanuel A., et al.
Publicado: (2021)

Application of Telemedicine in Diabetes Care: The Time is Now
por: Aberer, Felix, et al.
Publicado: (2021)

Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled Trials and Clinical Perspective
por: Aberer, Felix, et al.
Publicado: (2022)

Workflow for Criticality Assessment Applied in Biopharmaceutical Process Validation Stage 1
por: Zahel, Thomas, et al.
Publicado: (2017)

Long-Term Implanted cOFM Probe Causes Minimal Tissue Reaction in the Brain
por: Birngruber, Thomas, et al.
Publicado: (2014)

Assessment of Blood-Brain Barrier Function and the Neuroinflammatory Response in the Rat Brain by Using Cerebral Open Flow Microperfusion (cOFM)
por: Ghosh, Arijit, et al.
Publicado: (2014)

A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital
por: Aberer, Felix, et al.
Publicado: (2021)

Effects of vitamin D supplementation on FGF23: a randomized-controlled trial
por: Trummer, Christian, et al.
Publicado: (2018)

Reducing the impact of insulin sensitivity variability on glycaemic outcomes using separate stochastic models within the STAR glycaemic protocol
por: Thomas, Felicity, et al.
Publicado: (2014)

SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria
por: Mara, Elisabeth, et al.
Publicado: (2022)

Fluconazole and acetazolamide in the treatment of ectopic Cushing's syndrome with severe metabolic alkalosis
por: Schwetz, Verena, et al.
Publicado: (2015)

Langerhans Cell Histiocytosis Presenting as Uncontrolled Asthma
por: Rawlins, Frederic A., et al.
Publicado: (2013)

Subcutaneous glucose monitoring in patients with severe sepsis
por: Mader, JK, et al.
Publicado: (2007)

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
por: Zinman, Bernard, et al.
Publicado: (2017)

Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus
por: Mader, Julia K., et al.
Publicado: (2016)

Dietary glycaemic index and glycaemic load in relation to risk of breast cancer
por: Rigi, Somaye, et al.
Publicado: (2022)

Space GlucoseControl with the incorporated enhanced model predictive control algorithm is a safe and reliable tool for glycaemic control in medical ICU patients
por: Amrein, K, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5laap4t1fs327ejat0vtqnp1v4